Related Experiment Video
Updated: May 5, 2026

06:15
Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
Published on: November 10, 2023
1.5K
Latent Class Analysis Identifies Pulmonary Function Trajectory Phenotypes in Lung Transplant Recipients with Chronic
Summary
Identifying distinct FEV1 trajectories after lung transplant dysfunction (CLAD) reveals varying graft loss risks. A new classification tool aids in predicting outcomes for lung transplant recipients.
Area of Science:
- Pulmonary Medicine
- Transplantation Immunology
- Biostatistics
Background:
- Chronic lung allograft dysfunction (CLAD) is a major cause of lung transplant failure.
- Understanding FEV1 trajectories post-CLAD is crucial for prognostication.
- Early identification of risk phenotypes is needed for better patient management.
Purpose of the Study:
- To identify data-driven FEV1 trajectory phenotypes following CLAD.
- To associate these phenotypes with patient factors and graft loss.
- To develop a classification approach for predicting outcomes in prospective lung transplant recipients.
Main Methods:
- Analysis of adult first lung recipients with probable CLAD from two multicenter cohorts (CTOT-20 and LTOG).
- Characterization of FEV1 trajectories using joint latent class mixed models, accounting for informative censoring.
- Development and application of a classification and regression tree (CART) model for risk stratification.
Main Results:
- Four distinct early FEV1 trajectory classes were identified, showing significant differences in nine-month graft loss.
- Similar patterns were reproduced in a separate cohort, with an additional class showing early FEV1 improvement.
- A CART model demonstrated good discrimination and consistent class assignment across cohorts, with clear risk gradients identified.
Conclusions:
- Reproducible and clinically meaningful early post-CLAD FEV1 trajectory phenotypes with differential graft loss risks were identified.
- These phenotypes and a classification tool can support risk stratification and improve prognostication.
- The findings may enhance clinical trial enrichment and patient management strategies.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
906
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
906
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
40
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
40
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
5.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
5.0K
Pulmonary Tuberculosis III
1.8K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.8K
Chronic Obstructive Pulmonary Disease-I: Introduction
4.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.0K
COPD: Pathogenesis and Clinical Features
2.1K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.1K

